Search results
Results from the WOW.Com Content Network
The activity of each statin is dependent on the binding affinity of the compound for the substrate site and the length of time it binds to the site. [5] Type 2 statins have unique fluorophenyl group that causes additional polar interaction between the enzyme and the statins, which results in a tighter binding to the enzyme.
Ezetimibe/atorvastatin (trade names Liptruzet, Atozet) is a cholesterol lowering combination drug. In the United States, it was approved in May 2013, by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet. [ 1 ]
Administration of atorvastatin with food produces a 25% reduction in C max (rate of absorption) and a 9% reduction in AUC (extent of absorption), although food does not affect the plasma LDL-C-lowering efficacy of atorvastatin. Evening dose administration is known to reduce the C max and AUC by 30% each. However, time of administration does not ...
Consuming more than 45% of daily calories after 5 p.m. can contribute to greater risk of type 2 diabetes, cardiovascular problems, and chronic inflammation, a recent study suggests.
There’s no set cut-off time, as the drug was originally designed as a diabetes medication and intended for long-term use. If you’re tolerating it well and it’s working for you, you can take ...
The study, published in the Journal of the American College of Cardiology, used Merck's Zocor, but it seems safe to assume that other statins -- Pfizer's Lipitor and AstraZeneca's Crestor -- would ...
Time to Burn may refer to: Time to Burn (Giant album), 1992; Time to Burn (Taking Dawn album), 2010 "Time to Burn" (The Rasmus song), a song by the Rasmus from the album Dead Letters "Time to Burn" (Storm song), a song by Storm, 2000 "Time to Burn", a song by Peter Hammill from the album In a Foreign Town "Time to Burn", a song by Dio from the ...
Statins are linked to better health outcomes in older adults over the age of 70 with or without previous cardiovascular disease, a new study finds.